Roivant Sciences Ltd (ROIV)

Total asset turnover

Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Revenue (ttm) US$ in thousands 76,195 97,555 125,677 158,303 124,795 123,241 103,153 78,585 61,280 43,127 50,416 51,870 55,286 61,209 42,618 29,954 23,795 8,649
Total assets US$ in thousands 5,436,940 5,792,340 6,206,030 6,496,450 7,222,480 7,312,680 2,065,540 2,136,650 2,389,600 2,202,960 2,215,530 2,600,400 2,585,130 2,799,380 3,102,910 2,454,700 2,589,690 —
Total asset turnover 0.01 0.02 0.02 0.02 0.02 0.02 0.05 0.04 0.03 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 —

March 31, 2025 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $76,195K ÷ $5,436,940K
= 0.01

Total asset turnover is a financial ratio that measures a company's efficiency in generating sales revenue from its assets. It indicates how well a company is utilizing its assets to generate revenue. A higher total asset turnover ratio typically suggests better asset utilization.

In the case of Roivant Sciences Ltd, the total asset turnover ratio has been relatively stable over the past few years, ranging from 0.01 to 0.05. From December 31, 2020, to March 31, 2025, the total asset turnover ratio fluctuated within this range.

The ratio increased gradually from 0.01 in March 2021 to 0.05 in September 30, 2023, indicating an improvement in the company's efficiency in generating sales from its assets during this period. However, there was a slight decline to 0.02 by December 31, 2023, and the ratio remained around 0.02 in subsequent periods up to March 31, 2025.

Overall, Roivant Sciences Ltd's total asset turnover ratio suggests a moderate level of efficiency in utilizing its assets to generate revenue. The company may benefit from further optimizing its asset utilization to improve this ratio in the future and enhance its overall financial performance.